Similarly, per-patient comparison of MHC-II scores show that all three groups of CD8+ T cells have significantly lower expression in PDAC than BCC - in particular, the majority of effector and memory CD8+ T cells in PDAC exhibit virtually no MHC-II expression (Figure 2G). The gene discussed is CD8A; the disease is skin basal cell carcinoma.